Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

NCT01353079 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy

Interventions

BIOLOGICAL: Short Ragweed Pollen Allergenic Extract
BIOLOGICAL: Placebo

Sponsor

Greer Laboratories